Shiferman Gregory L.
Insider CIK 2041689 · SAGE See Remarks · VYGR SVP and General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VYGR Voyager Therapeutics, Inc. | A Award | 2026-04-01 | 2026-04-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2026-01-06 | 2026-01-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 10,000 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 28,000 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer | 2025-07-31 | 2025-07-31 | 23,735 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | U Tender | 2025-07-31 | 2025-07-31 | 7,215 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-06-24 | 2025-06-26 | 79 | $9.22 | $728 | 30,950 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-04-10 | 2025-04-11 | 176 | $6.91 | $1.2K | 31,029 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2025-04-10 | 2025-04-11 | 525 | — | $0 | 31,205 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-03-24 | 2025-03-26 | 79 | $8.21 | $649 | 30,680 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-02-24 | 2025-02-25 | 2,502 | $7.49 | $18.7K | 30,759 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-02-13 | 2025-02-14 | 376 | $7.18 | $2.7K | 33,512 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-02-13 | 2025-02-14 | 251 | $7.18 | $1.8K | 33,261 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2025-01-16 | 2025-01-21 | 28,000 | — | $0 | 28,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2025-01-16 | 2025-01-21 | 14,000 | — | $0 | 33,888 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2024-12-24 | 2024-12-27 | 79 | $5.48 | $433 | 19,888 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-11-01 | 2024-11-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2024-11-01 | 2024-11-01 | 5,000 | — | $0 | 19,967 | SEC↗ |